Dr. Steven M. Albert — (212) 305-2503
Epidemiologic studies investigating the cognitive basis of functional competency of patients with HIV, Alzheimer disease and ALS. Ongoing studies of disease-related changes contributing to patient quality of life, nursing home placement, hospitalization and home care costs.
Dr. Jennie Kline — (212) 960-5852
Epidemiology of spontaneous abortion; chromosomal disorders including trisomy; autism and other selected developmental disorders.
Dr. Ruth Ottman — (212) 305-9188
Neuroepidemiology and genetic studies of epilepsy, Parkinson disease and ALS.
Dr. Nicole Schupf — (212) 305-2381
Genetic epidemiology of Down syndrome and Alzheimer disease.
Dr. Zena Stein — (212) 305-9081
Epidemiology of mental retardation and developmental brain diseases.
Dr. W. Allen Hauser — (212) 305-6866
Associate Director (see Neuroepidemiology under the Comprehensive Epilepsy Center).
Dr. Karen S. Marder — (212) 305-9194
(see Aging and Dementia)
Dr. Karen L. Bell — (212) 305-9194
(see Aging and Dementia)
Dr. Laurence C. Honig — (212) 305-9194
Dr. Elan D. Louis — (212) 305-5277
(see Movement Disorders)
Dr. Scott Small — (212) 305-9194
(see Aging and Dementia)
Dr. Yaakov Stern — (212) 305-9194
Head, Cognitive Neuroscience
Experimental and neuroimaging approaches to cognitive issues in normal aging and diseases of the aging brain (including Alzheimer, Parkinson and Huntington diseases). Current experimental cognitive studies include: source memory, working memory, priming, and the interplay between explicit recollection and familiarity in normal aging; basic timing mechanisms in normal aging and Parkinson disease; language and working memory in Alzheimer disease; and effects of literacy, education, ethnicity and acculturation on neuropsychological task performance in cognitive neuroimaging. Cognitive neuroimaging studies include: network changes in mediating recognition and working memory and cognitive reserve in normal aging and Alzheimer disease (H2 15O PET and fMRI); age priming in young adults and normal aging (ER-fMRI) executive function in normal aging and Huntington disease (fMRI), and effects of estrogen on recognition and source memory in elderly women (ERP).